Publicações

Quality of Life Outcomes in Apollo, the Phase 3 Trial of the Rnai Therapeutic Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis

AuthID
P-00R-VY6

Author(s)

Obici, L

Berk, JL

Gonzalez Duarte, A

Coelho, T

Gillmore, J

Schmidt, HHJ

Schilling, M

Yamashita, T

Labeyrie, C

Brannagan, TH

Ajroud Driss, S

Gorevic, P

Kristen, AV

Franklin, J

Chen, JH

Sweetser, MT

Wang, JJ

Adams, D

Tipo de Documento

Article

Year published

2020

Publicado

in AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, ISSN: 1350-6129

Volume: 27, Número: 3, Páginas: 153-162 (10)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1080/13506129.2020.1730790

Pubmed: 32131641

SCOPUS: 2-s2.0-85081229533

Wos: WOS:000518442600001

Source Identifiers

ISSN: 1350-6129

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Quality of Life Outcomes in Apollo, the Phase 3 Trial of the Rnai Therapeutic Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Quality of Life Outcomes in Apollo, the Phase 3 Trial of the Rnai Therapeutic Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis

Links Úteis

Ajuda